Search

Search Constraints

You searched for: Author/Creator Geoerger, Birgit

Search Results

21. Establishment and characterization of in vivo orthotopic bioluminescent xenograft models from human osteosarcoma cell lines in Swiss nude and NSG mice. (23rd February 2018)

22. First-in-child phase I/II study of the dual mTORC1/2 inhibitor vistusertib (AZD2014) as monotherapy and in combination with topotecan-temozolomide in children with advanced malignancies: arms E and F of the AcSé-ESMART trial. (November 2021)

23. From class waivers to precision medicine in paediatric oncology. Issue 7 (July 2017)

24. HGG-11. Clinical characteristics and clinical evolution of a large cohort of pediatric patients with primary central nervous system (CNS) tumors and tropomyosin receptor kinase (TRK) fusion. (3rd June 2022)

25. HGG-18. Long-term efficacy and safety of larotrectinib in paediatric patients with tropomyosin receptor kinase (TRK) fusion-positive primary central nervous system (CNS) tumours. (3rd June 2022)

26. Immunodynamics of explanted human tumors for immuno‐oncology. Issue 1 (29th December 2020)

27. Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium. (December 2020)

28. Implementation of mechanism of action biology-driven early drug development for children with cancer. (July 2016)

29. Infantile Rhabdomyosarcomas With VGLL2 Rearrangement Are Not Always an Indolent Disease: A Study of 4 Aggressive Cases With Clinical, Pathologic, Molecular, and Radiologic Findings. (June 2021)

30. Inhibition of the NOTCH pathway using γ-secretase inhibitor RO4929097 has limited antitumor activity in established glial tumors. Issue 3 (March 2015)